Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

BACKGROUND AND OBJECTIVE: Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the insulin lispro pharmacokinetics and glucodynamics, safety and tolerability of UR...

Descripción completa

Detalles Bibliográficos
Autores principales: Leohr, Jennifer, Dellva, Mary Anne, Coutant, David E., LaBell, Elizabeth, Heise, Tim, Andersen, Grit, Zijlstra, Eric, Hermanski, Lidia, Nosek, Leszek, Linnebjerg, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716902/
https://www.ncbi.nlm.nih.gov/pubmed/32468448
http://dx.doi.org/10.1007/s40262-020-00901-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716902/
https://www.ncbi.nlm.nih.gov/pubmed/32468448
http://dx.doi.org/10.1007/s40262-020-00901-2

Ejemplares similares